A camelid antibody fragment inhibits the formation of amyloid fibrils by human lysozyme.

Схожие документы

• Engineering a camelid antibody fragment that binds to the active site of human lysozyme and inhibits its conversion into amyloid fibrils.
  по: Chan, P, и др.
  Опубликовано: (2008)
• Reduced global cooperativity is a common feature underlying the amyloidogenicity of pathogenic lysozyme mutations.
  по: Dumoulin, M, и др.
  Опубликовано: (2005)
• Local cooperativity in the unfolding of an amyloidogenic variant of human lysozyme.
  по: Canet, D, и др.
  Опубликовано: (2002)
• A nanobody binding to non-amyloidogenic regions of the protein human lysozyme enhances partial unfolding but inhibits amyloid fibril formation.
  по: De Genst, E, и др.
  Опубликовано: (2013)
• Investigation of non-covalent interactions of amyloidogenic human lysozyme variants and camelid antibodies
  по: Caddy, G, и др.
  Опубликовано: (2002)